APO LET 2.5 (Letrozole 2.5 mg)
Pill imprint APO LET 2.5 has been identified as Letrozole 2.5 mg.
Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- APO LET 2.5
- 2.5 mg
- Prescription only
- Drug Class:
- Aromatase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
- hydroxypropyl cellulose
polyethylene glycol 8000
sodium starch glycolate type A potato
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|68084-0803||Amerisource Health Services|
Note: Inactive ingredients may vary.
More about letrozole
- Other brands: Femara
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.